from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1425/-

LFCtreatmentdescriptionclass of inhibitor

-1.173

Amikacinug/mL Amikacintranslation

-1.186

Cap5-10ug/mL Capreomycintranslation

-2.252

Rox10-50 ug/mL Roxithromycintranslation

0.449

SM2-5 ug/mL Streptomycintranslation

-2.859

Tet5-10 ug/mL Tetracyclinetranslation

-0.874

Rif0.2-5ug/mL Rifampicintranscription

0.117

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.992

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.837

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.111

CPZ10-50 ug/mL Chlorpromazinerespiration

0.783

Clofazimine10-13 ug/mL Clofaziminerespiration

0.829

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.221

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.982

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.496

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.795

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.004

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.180

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.196

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.536

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.222

KCN5-20 ug/mL Potassium cyaniderespiration

-0.257

NaN30.2-2 mM Sodium aziderespiration

0.801

Nigericin50 uM Nigericinrespiration

0.453

TRC10-150 ug/mL Triclosanrespiration

-0.205

TRZ10-25 ug/mL Thioridazinerespiration

0.324

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.205

menadione6-10 ug/mL Menadionerespiration

0.297

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.180

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.408

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.283

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.761

NRP_1Non-replicating persistence stage 1dosRassociated

0.252

Amp0.2mg/mL AmpicillincellWall

0.029

Cephalexin20-100 ug/mL CephalexincellWall

-0.146

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.282

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.291

EMB10-20 ug/mL EthambutolcellWall

-0.197

Eta12-40 ug/mL EthionamidecellWall

-0.006

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.165

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.383

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.850

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.337

BZA0.12 mg/mL BenzamidearomaticAmides

-0.421

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.421

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.688

H2O24 mM hydrogen peroxideDNAdamaging

0.197

Levo10 ug/mL LevofloxacinDNAdamaging

-0.329

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.026

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.091

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.167

UVUV-irradiationDNAdamaging

0.111

ARP41-4 ug/mL Antitubercular compound ARP4?

0.577

Antimycin12.5-50 ug/mL Antimycin A?

0.128

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.428

PA_110-50 ug/mL Antitubercular compound PA-1?

0.117

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.135

PA8240.2-2 ug/mL PA-824?

-0.444

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.299

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.789

Verapamil50 uM Verapamil?

0.789

mercaptoethanol2 mM 2-Mercaptoethanol?

0.291

methoxatin10-20 ug/mL Methoxatin?